LATEST NEWS
Unveiling a new hope in the battle against elusive cancers, FDA’s D.I.S.C.O. Burst Edition celebrates the approval of Polivy for the treatment of diffuse large B-cell lymphoma and high-grade B-cell lymphoma. A major milestone in the world of oncology, this breakthrough offers fresh prospects for patients facing these challenging diagnoses.
Thank you to Dr Sundar Jagannath, MD @TischCancer & @AACR #AACR24 for sitting down with us to discuss his research on #linvoseltamab for #RRMM Video will be released tomorrow after the presentation https://www.abstractsonline.com/pp8 @Regeneron
2Oncology Conference Videos
Oncology News
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…
Dipti Patel-Donnelly, a medical oncologist at the Virginia Cancer Specialists, leads a study titled “How…
By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…
By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…
By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…
By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…
Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
By: Hope Rugo, MD Date: 12/9/2023 At the SABCS 2023 conference, medical oncologist Hope Rugo…